Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vrenken

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Neuroimage|November 26, 2008
Regional DTI differences in multiple sclerosis patientsS D Roosendaal, J J G Geurts, H Vrenken, et al.
Neurology|March 18, 2009
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measuresW J P Henneman, J D Sluimer, J Barnes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2009
Association between MRI parameters and the MS severity scale: a 12 year follow-up studyA Minneboo, B M J Uitdehaag, P Jongen, et al.
AJNR. American Journal of Neuroradiology|December 15, 2015
Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple SclerosisY Liu, C Lukas, M D Steenwijk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2014
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosisL J Balk, M D Steenwijk, P Tewarie, et al.
Dementia and Geriatric Cognitive Disorders|April 15, 2010
Neurological signs in relation to white matter hyperintensity volumes in memory clinic patientsS S Staekenborg, H de Waal, F Admiraal-Behloul, et al.
Neurology|June 16, 2010
Incidence of cerebral microbleeds: a longitudinal study in a memory clinic populationJ D C Goos, W J P Henneman, J D Sluimer, et al.
Multiple Sclerosis and Related Disorders|May 21, 2024
Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical dataS Noteboom, E M M Strijbis, E M E Coerver, et al.
Journal of Neurology|July 19, 2023
Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIRSamantha Noteboom, D R van Nederpelt, A Bajrami, et al.
European Journal of Neurology|January 11, 2019
Predicting clinical progression in multiple sclerosis after 6 and 12 yearsI Dekker, A J C Eijlers, V Popescu, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Neuroimage|November 26, 2008
Regional DTI differences in multiple sclerosis patientsS D Roosendaal, J J G Geurts, H Vrenken, et al.
Neurology|March 18, 2009
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measuresW J P Henneman, J D Sluimer, J Barnes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2009
Association between MRI parameters and the MS severity scale: a 12 year follow-up studyA Minneboo, B M J Uitdehaag, P Jongen, et al.
AJNR. American Journal of Neuroradiology|December 15, 2015
Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple SclerosisY Liu, C Lukas, M D Steenwijk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2014
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosisL J Balk, M D Steenwijk, P Tewarie, et al.
Dementia and Geriatric Cognitive Disorders|April 15, 2010
Neurological signs in relation to white matter hyperintensity volumes in memory clinic patientsS S Staekenborg, H de Waal, F Admiraal-Behloul, et al.
Neurology|June 16, 2010
Incidence of cerebral microbleeds: a longitudinal study in a memory clinic populationJ D C Goos, W J P Henneman, J D Sluimer, et al.
Multiple Sclerosis and Related Disorders|May 21, 2024
Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical dataS Noteboom, E M M Strijbis, E M E Coerver, et al.
Journal of Neurology|July 19, 2023
Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIRSamantha Noteboom, D R van Nederpelt, A Bajrami, et al.
European Journal of Neurology|January 11, 2019
Predicting clinical progression in multiple sclerosis after 6 and 12 yearsI Dekker, A J C Eijlers, V Popescu, et al.
Pageof 5